Cargando…

Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future

Detalles Bibliográficos
Autores principales:	Mahfoud, Felix, Schmieder, Roland E, Azizi, Michel, Pathak, Atul, Sievert, Horst, Tsioufis, Costas, Zeller, Thomas, Bertog, Stefan, Blankestijn, Peter J, Böhm, Michael, Burnier, Michel, Chatellier, Gilles, Durand Zaleski, Isabelle, Ewen, Sebastian, Grassi, Guido, Joner, Michael, Kjeldsen, Sverre E, Lobo, Melvin D, Lotan, Chaim, Lüscher, Thomas Felix, Parati, Gianfranco, Rossignol, Patrick, Ruilope, Luis, Sharif, Faisal, van Leeuwen, Evert, Volpe, Massimo, Windecker, Stephan, Witkowski, Adam, Wijns, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837218/ https://www.ncbi.nlm.nih.gov/pubmed/28475773 http://dx.doi.org/10.1093/eurheartj/ehx215

Ejemplares similares

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
por: Mahfoud, Felix, et al.
Publicado: (2020)

Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension
por: Schmieder, Roland, et al.
Publicado: (2023)

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
por: Mahfoud, Felix, et al.
Publicado: (2019)

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension
por: Mahfoud, Felix, et al.
Publicado: (2021)

Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D)
por: Schernthaner, Guntram, et al.
Publicado: (2017)

Correction to: One‑year clinical outcomes in patients with renal insuffciency after contemporary PCI: data from a multicenter registry
por: Scholz, Sean S., et al.
Publicado: (2020)

One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry
por: Scholz, Sean S., et al.
Publicado: (2019)

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Renal Denervation for Chronic Heart Failure: Background and Pathophysiological Rationale
por: Böhm, Michael, et al.
Publicado: (2017)

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy
por: Kario, Kazuomi, et al.
Publicado: (2019)

Off-the-shelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID-19) pandemic
por: Scheller, Bruno, et al.
Publicado: (2020)

Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry
por: Schmieder, Roland E, et al.
Publicado: (2022)

Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I (f) Inhibitor Ivabradine Trial (SHIFT) Trial
por: Böhm, Michael, et al.
Publicado: (2016)

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
por: Kario, Kazuomi, et al.
Publicado: (2022)

Cardiovascular risk reduction by reversing endothelial dysfunction:ARBs, ACE inhibitors, or both? Expectations from The ONTARGET Trial Programme
por: Ruilope, Luis Miguel, et al.
Publicado: (2007)

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
por: Mahfoud, Felix, et al.
Publicado: (2023)

Correction to: Off‑the‑shelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID‑19) pandemic
por: Scheller, Bruno, et al.
Publicado: (2020)

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design
por: Böhm, Michael, et al.
Publicado: (2020)

Treating resistant hypertension: role of renal denervation
por: Urban, Daniel, et al.
Publicado: (2013)

Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill
por: Burnier, Michel
Publicado: (2010)

Is There a Threshold for Medication Adherence? Lessons Learnt From Electronic Monitoring of Drug Adherence
por: Burnier, Michel
Publicado: (2019)

Renin-Angiotensin System Blockade in Advanced Kidney Disease: Stop or Continue?
por: Burnier, Michel
Publicado: (2020)

Commentary: Statistical Adhockeries Are No Criteria for Legal Decisions—The Case of the Expert Medical Report on the Assessment of Urine Specimens Collected Among Athletes Having Participated to the Vancouver and Sochi Winter Olympic Games
por: Burnier, Michel
Publicado: (2019)

Sodium-glucose cotransporter 2 (SGLT-2) inhibition and kidney protection: Does improvement in kidney hypoxia play a role?
por: Burnier, Michel
Publicado: (2021)

Editorial: Insights in hypertension: 2021
por: Burnier, Michel
Publicado: (2022)

Gout and hyperuricaemia: modifiable cardiovascular risk factors?
por: Burnier, Michel
Publicado: (2023)

Reduction of Outflow Tract Obstruction After PCI to Proximal LAD in a Patient With HOCM
por: Al Ali, Radwan, et al.
Publicado: (2020)

Renal denervation in the antihypertensive arsenal – knowns and known unknowns
por: Messerli, Franz H., et al.
Publicado: (2023)

Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure
por: Phan, Olivier, et al.
Publicado: (2015)

Renal denervation in hypertensive patients not on blood pressure lowering drugs
por: De Jager, Rosa L., et al.
Publicado: (2016)

The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes: A Subanalysis of the ROADMAP Study
por: Schmieder, Roland E., et al.
Publicado: (2016)

Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
por: Weber, Michael A., et al.
Publicado: (2022)

Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations
por: Carrera, Fernando, et al.
Publicado: (2009)

Editorial: Hypertension in the Elderly
por: Coca, Antonio, et al.
Publicado: (2021)

The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry
por: Bramlage, Peter, et al.
Publicado: (2015)

EARLY Treatment with azilsartan compared to ACE-inhibitors in anti-hypertensive therapy – rationale and design of the EARLY hypertension registry
por: Gitt, Anselm K, et al.
Publicado: (2013)

Prediction of conduction disturbances in patients undergoing transcatheter aortic valve replacement
por: Pavlicek, Valérie, et al.
Publicado: (2023)

Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
por: Maillard, Marc P, et al.
Publicado: (2007)

Pacemaker‐Based Cardiac Neuromodulation Therapy for the Treatment of Hypertension: The New Kid on the Block
por: Lauder, Lucas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nou7t9sk60dkpreep5o1lr5ohn